World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
47
Citations
7805
World Ranking
6468
National Ranking
2812

Best Publications

  • βSubunits Promote K+ Channel Surface Expression through Effects Early in Biosynthesis

    Gongyi Shi;Kensuke Nakahira;Scott Hammond;Kenneth J Rhodes

  • Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications

    Robert H. Ring;Jessica E. Malberg;Lisa Potestio;Julia Ping

  • From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes.

    Darlene Deecher;Terrance H. Andree;Diane Sloan;Lee E. Schechter

  • Innovative Approaches for the Development of Antidepressant Drugs: Current and Future Strategies

    Lee E. Schechter;Robert H. Ring;Chad E. Beyer;Zoë A. Hughes

  • Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.

    Lee E Schechter;Qian Lin;Deborah L Smith;Guoming Zhang

  • The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.

    Unknown

  • Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.

    Darrick T. Balu;Brian A. Hoshaw;Jessica E. Malberg;Sharon Rosenzweig-Lipson

  • Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs

    Jessica E Malberg;Lee E Schechter

  • Voltage-Gated K+ Channel β Subunits: Expression and Distribution of Kvβ1 and Kvβ2 in Adult Rat Brain

    Kenneth J. Rhodes;Michael M. Monaghan;Nestor X. Barrezueta;Stanley Nawoschik

  • Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties

    Lee E Schechter;Deborah Smith;Sharon Rosenzweig-Lipson;Stacey Sukoff

  • The Central 5‐HT1A Receptors: Pharmacological, Biochemical, Functional, and Regulatory Propertiesa

    M. Hamon;H. Gozlan;S. El Mestikawy;M. B. Emerit

  • Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist

    Robert H. Ring;Lee E. Schechter;Sarah K. Leonard;Jason M. Dwyer

  • Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.

    Sarah K. Leonard;Jason M. Dwyer;Stacey J. Sukoff Rizzo;Brian Platt

  • Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.

    L E Schechter;F J Bolaños;H Gozlan;L Lanfumey

  • Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists.

    Derek C. Cole;William J. Lennox;Sabrina Lombardi;John W. Ellingboe

  • WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Anorectic Activity

    John Dunlop;Annmarie L. Sabb;Hossein Mazandarani;Jean Zhang

  • The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer s disease.

    L.E. Schechter;L.A. Dawson;Josie A. Harder

  • Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like Effects

    Jessica E Malberg;Brian Platt;Stacey J Sukoff Rizzo;Robert H Ring

  • WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent.

    Zoë A. Hughes;Feng Liu;Brian J. Platt;Jason M. Dwyer

  • Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats.

    Gregory V. Carr;Lee E. Schechter;Irwin Lucki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: